Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.
Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. Grady WM, et al. Among authors: toro tt. Nat Genet. 2000 Sep;26(1):16-7. doi: 10.1038/79120. Nat Genet. 2000. PMID: 10973239
Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
Humar B, Toro T, Graziano F, Müller H, Dobbie Z, Kwang-Yang H, Eng C, Hampel H, Gilbert D, Winship I, Parry S, Ward R, Findlay M, Christian A, Tucker M, Tucker K, Merriman T, Guilford P. Humar B, et al. Hum Mutat. 2002 May;19(5):518-25. doi: 10.1002/humu.10067. Hum Mutat. 2002. PMID: 11968084 Clinical Trial.
Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
Humar B, Graziano F, Cascinu S, Catalano V, Ruzzo AM, Magnani M, Toro T, Burchill T, Futschik ME, Merriman T, Guilford P. Humar B, et al. Oncogene. 2002 Nov 21;21(53):8192-5. doi: 10.1038/sj.onc.1205921. Oncogene. 2002. PMID: 12444556
E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.
Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, Toro TT, Lee D, Limacher JM, Shaw DW, Findlay MP, Reeve AE. Guilford PJ, et al. Among authors: toro tt. Hum Mutat. 1999;14(3):249-55. doi: 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9. Hum Mutat. 1999. PMID: 10477433
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.
Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Höglund P, Järvinen H, Kristo P, Pelin K, Ridanpää M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA. Hemminki A, et al. Nature. 1998 Jan 8;391(6663):184-7. doi: 10.1038/34432. Nature. 1998. PMID: 9428765
Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
Holyoake A, O'Sullivan P, Pollock R, Best T, Watanabe J, Kajita Y, Matsui Y, Ito M, Nishiyama H, Kerr N, da Silva Tatley F, Cambridge L, Toro T, Ogawa O, Guilford P. Holyoake A, et al. Clin Cancer Res. 2008 Feb 1;14(3):742-9. doi: 10.1158/1078-0432.CCR-07-1672. Clin Cancer Res. 2008. PMID: 18245534
Predicting clinical outcome through molecular profiling in stage III melanoma.
John T, Black MA, Toro TT, Leader D, Gedye CA, Davis ID, Guilford PJ, Cebon JS. John T, et al. Among authors: toro tt. Clin Cancer Res. 2008 Aug 15;14(16):5173-80. doi: 10.1158/1078-0432.CCR-07-4170. Clin Cancer Res. 2008. PMID: 18698035 Free article.
A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria.
O'Sullivan P, Sharples K, Dalphin M, Davidson P, Gilling P, Cambridge L, Harvey J, Toro T, Giles N, Luxmanan C, Alves CF, Yoon HS, Hinder V, Masters J, Kennedy-Smith A, Beaven T, Guilford PJ. O'Sullivan P, et al. J Urol. 2012 Sep;188(3):741-7. doi: 10.1016/j.juro.2012.05.003. Epub 2012 Jul 19. J Urol. 2012. PMID: 22818138
Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov N, Toro T, Merrie AE, van Rij A, Yoon HS, McCall JL, Siewert JR, Holzmann B, Reeve AE. Lin YH, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):498-507. doi: 10.1158/1078-0432.CCR-05-2734. Clin Cancer Res. 2007. PMID: 17255271